120 related articles for article (PubMed ID: 38701136)
1. Pleiotrophin serum level and metastasis occurrence in breast cancer patients.
Ikhlas M; Ferianto D; Syamsu SA; Ganda IJ; Smaradania N; Sampepajung E; Anggita CA; Faruk M
Breast Dis; 2024; 43(1):93-98. PubMed ID: 38701136
[TBL] [Abstract][Full Text] [Related]
2. Pleiotrophin as a potential biomarker in breast cancer patients.
Ma J; Kong Y; Nan H; Qu S; Fu X; Jiang L; Wang W; Guo H; Zhao S; He J; Nan K
Clin Chim Acta; 2017 Mar; 466():6-12. PubMed ID: 28041942
[TBL] [Abstract][Full Text] [Related]
3. Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer.
Xu C; Wang Y; Yuan Q; Wang W; Chi C; Zhang Q; Zhang X
J Cell Mol Med; 2019 Mar; 23(3):2077-2082. PubMed ID: 30635982
[TBL] [Abstract][Full Text] [Related]
4. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
5. Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer.
Kong Y; Bai PS; Nan KJ; Sun H; Chen NZ; Qi XG
Int J Colorectal Dis; 2012 Mar; 27(3):287-98. PubMed ID: 22065111
[TBL] [Abstract][Full Text] [Related]
6. Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer.
Liu S; Shen M; Hsu EC; Zhang CA; Garcia-Marques F; Nolley R; Koul K; Rice MA; Aslan M; Pitteri SJ; Massie C; George A; Brooks JD; Gnanapragasam VJ; Stoyanova T
Br J Cancer; 2021 Mar; 124(5):896-900. PubMed ID: 33288843
[TBL] [Abstract][Full Text] [Related]
7. Pleiotrophin, the angiogenic and mitogenic growth factor: levels in serum and synovial fluid in rheumatoid arthritis and osteoarthritis : And correlation with clinical, laboratory and radiological indices.
Fadda SMH; Bassyouni IH; Khalifa RH; Elsaid NY
Z Rheumatol; 2018 May; 77(4):322-329. PubMed ID: 27904997
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.
Zhou J; Yang Y; Zhang Y; Liu H; Dou Q
PLoS One; 2018; 13(11):e0207473. PubMed ID: 30427932
[TBL] [Abstract][Full Text] [Related]
9. Pleiotrophin Serum Level is Increased in Relapsing-Remitting Multiple Sclerosis and Correlates With Sex, BMI and Treatment.
Reyes-Mata PM; Rojas-Mayorquín AE; Carrera-Quintanar L; González-Castillo C; Mireles-Ramírez MA; Guerrero-García JJ; Ortuño-Sahagún D
Arch Med Res; 2022 Jan; 53(1):59-68. PubMed ID: 34247888
[TBL] [Abstract][Full Text] [Related]
10. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
Riegel AT; Wellstein A
Breast Cancer Res Treat; 1994; 31(2-3):309-14. PubMed ID: 7533562
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of pleiotrophin increases the risk of preeclampsia following vitrified-thawed embryo transfer.
Liu S; Wang F; Liu G
Int J Oncol; 2018 Nov; 53(5):1847-1856. PubMed ID: 30226583
[TBL] [Abstract][Full Text] [Related]
12. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
13. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant.
Zhang N; Zhong R; Wang ZY; Deuel TF
J Biol Chem; 1997 Jul; 272(27):16733-6. PubMed ID: 9201975
[TBL] [Abstract][Full Text] [Related]
14. Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.
Chang Y; Zuka M; Perez-Pinera P; Astudillo A; Mortimer J; Berenson JR; Deuel TF
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10888-93. PubMed ID: 17578909
[TBL] [Abstract][Full Text] [Related]
15. Pleiotrophin drives a prometastatic immune niche in breast cancer.
Ganguly D; Schmidt MO; Coleman M; Ngo TC; Sorrelle N; Dominguez ATA; Murimwa GZ; Toombs JE; Lewis C; Fang YV; Valdes-Mora F; Gallego-Ortega D; Wellstein A; Brekken RA
J Exp Med; 2023 May; 220(5):. PubMed ID: 36828390
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
Chen C; Chen Q; Dong Y; Liu X
Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
[TBL] [Abstract][Full Text] [Related]
18. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential.
Wu H; Barusevicius A; Babb J; Klein-Szanto A; Godwin A; Elenitsas R; Gelfand JM; Lessin S; Seykora JT
J Cutan Pathol; 2005 Feb; 32(2):125-30. PubMed ID: 15606670
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel metastatic breast cancer score based on hyaluronic acid metabolism.
El-Mezayen HA; Toson el-SA; Darwish H; Metwally FM
Med Oncol; 2013 Mar; 30(1):404. PubMed ID: 23275142
[TBL] [Abstract][Full Text] [Related]
20. Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status.
Yeh HS; Chen H; Manyak SJ; Swift RA; Campbell RA; Wang C; Li M; Lee HJ; Waterman G; Gordon MS; Ma J; Bonavida B; Berenson JR
Br J Haematol; 2006 Jun; 133(5):526-9. PubMed ID: 16681640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
